Astek Acquires Keyrus’ Life Sciences CRO Activities

Astek Group has recently finalized the acquisition of Keyrus’ Life Sciences CRO activities, thereby strengthening its presence in the life sciences sector by combining clinical expertise with technological innovation. Astek Group has recently finalized the acquisition of Keyrus’ Life Sciences CRO ac

The acquired operations, now consolidated under the ALSINOVA brand, include more than 230 professionals based in France, Belgium, Canada, and the United States. This acquisition is part of Astek’s strategy to become a key player among mid-sized Contract Research Organizations (CROs), by offering innovative solutions tailored to the specific needs of its clients.

De Grandpré Chait is proud to have supported Groupe Astek in this pivotal stage of its growth — a transaction led by David Dropsy, Partner and Head of the Transactional Group.

To learn more, read the official press release (in French only).